The 36-month beta value for COSM is at 3.15. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for COSM is 18.15M, and currently, shorts hold a 4.86% of that float. The average trading volume for COSM on February 03, 2025 was 435.96K shares.
COSM) stock’s latest price update
Cosmos Health Inc (NASDAQ: COSM)’s stock price has gone rise by 7.06 in comparison to its previous close of 0.66, however, the company has experienced a -9.65% decrease in its stock price over the last five trading days. accessnewswire.com reported 2025-01-28 that CHICAGO, IL / ACCESS Newswire / January 28, 2025 / Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that, on January 27, 2025, its wholly owned subsidiary, CosmoFarm S.A. (the “Issuer” or “CosmoFarm”), entered into an agreement with a European bank to issue a €2,200,000 (approximately $2,293,830) secured bond (the “Loan”).
COSM’s Market Performance
COSM’s stock has fallen by -9.65% in the past week, with a monthly rise of 5.91% and a quarterly drop of -3.41%. The volatility ratio for the week is 13.28% while the volatility levels for the last 30 days are 14.81% for Cosmos Health Inc The simple moving average for the past 20 days is -3.47% for COSM’s stock, with a -16.12% simple moving average for the past 200 days.
COSM Trading at -2.59% from the 50-Day Moving Average
After a stumble in the market that brought COSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.19% of loss for the given period.
Volatility was left at 14.81%, however, over the last 30 days, the volatility rate increased by 13.28%, as shares surge +5.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.40% upper at present.
During the last 5 trading sessions, COSM fell by -9.65%, which changed the moving average for the period of 200-days by +8.92% in comparison to the 20-day moving average, which settled at $0.7334. In addition, Cosmos Health Inc saw 5.83% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COSM starting from Siokas Grigorios, who purchase 51,414 shares at the price of $0.66 back on Jan 30 ’25. After this action, Siokas Grigorios now owns 4,255,103 shares of Cosmos Health Inc, valued at $34,000 using the latest closing price.
Siokas Grigorios, the Chief Executive Officer of Cosmos Health Inc, purchase 38,900 shares at $0.77 during a trade that took place back on Jan 22 ’25, which means that Siokas Grigorios is holding 4,203,689 shares at $30,000 based on the most recent closing price.
Stock Fundamentals for COSM
Current profitability levels for the company are sitting at:
- -0.36 for the present operating margin
- 0.08 for the gross margin
The net margin for Cosmos Health Inc stands at -0.36. The total capital return value is set at -0.51. Equity return is now at value -46.31, with -26.60 for asset returns.
Based on Cosmos Health Inc (COSM), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -0.33. The debt to equity ratio resting at 0.32. The interest coverage ratio of the stock is -19.59.
Currently, EBITDA for the company is -17.06 million with net debt to EBITDA at -0.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.43. The receivables turnover for the company is 3.21for trailing twelve months and the total asset turnover is 0.87. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
In conclusion, Cosmos Health Inc (COSM) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
